Table 2.
Type 2 diabetes mellitus characteristics and mode of disease management.
| Variable | Participants (n=86) | |
| Diagnosis length in years, mean (SD) | 9.7 (7.0) | |
| HbA1ca value, mean (SD) | 7.1 (1.4) | |
| Uses oral T2DMb medication, n (%) | 80 (93) | |
| Uses insulin, n (%) | 24 (28) | |
| Unaware of HbA1c value, n (%) | 17 (20) | |
| Reported a hypoglycemic event in the past 12 months, n (%) | 35 (41) | |
| Reported a nocturnal hypoglycemic event in the past 4 weeks, n (%) | 5 (6) | |
| Timing of hypoglycemic event, n (%) |
|
|
|
|
Day | 8 (62) |
|
|
Night | 5 (39) |
aHbA1c: glycated hemoglobin.
bT2DM: type 2 diabetes mellitus.